Die Pentixapharm AG ist ein 2019 gegründetes biopharmazeutisches Unternehmen, das sich auf die Entwicklung von Radiopharmazeutika fokussiert. Das IPO erfolgte im Oktober 2024.

COMPANY

Pentixapharm Holding

INVESTOR TERMSHEET

#BGFL app

#BGFL Publisher

PTP

LEI: 3912005VBOVXNDXEQZ36

SECTOR: Gesundheit SUB-SECTOR: Pharma

NAME

Pentixapharm Holding

WKN

A40AEG

ISIN

DE000A40AEG0

TICKER

PTP

INDEX

EXCHANGE

Xetra

BUY SELL

Made with ❤ von BGFL

#BGFL

Newswire

Ratings

#BGFL-nes Pentixapharm Holding: boersengefluester.de (BGFL) regularly writes extensive editorial articles for most of the companies in our database - especially those in the special stocks sector. Here we show you a list of the most recent articles by BGFL on the selected share.

21.11.2024	Pentixapharm Holding: Bislang unterschätzte Aktie
01.10.2024	Pentixapharm Holding: Seltene Kombination

Newswire Pentixapharm Holding: Official company news is an enormously important source of information for investors - especially if it is particularly price-sensitive and therefore subject to ad hoc disclosure. Here we show the reports provided by the IR portal EQS News on companies from the BGFL coverage universe.

12.11.2024	EQS-News: Pentixapharm Releases Interim Report for the Third Quarter of 2024
04.11.2024	EQS-News: Pentixapharm Welcomes CMS Decision to Enhance Reimbursement for Diagnostic Radiopharmaceuticals
29.10.2024	EQS-News: Pentixapharm Holding AG: US National Cancer Institute Starts Advanced Clinical Trial with PentixaFor
28.10.2024	EQS-News: Nuclear Medicine Specialist Ken Herrmann Joins Supervisory Board of Pentixapharm Holding AG
25.10.2024	EQS-News: Pentixapharm Holding AG: Upcoming Changes in the Management and Supervisory Boards of the Pentixapharm Group

Resaerch for Pentixapharm Holding: Independent research is hard to find, especially in the speciality stocks sector. However, there are a number of firms that regularly produce meaningful analyses of the companies they cover. As a rule, this is paid research - but the analyses are definitely worth reading.

No data

The #BGFL Coverage App Gallery

Visualisation of financial information has been one of boersengefluester.de's (BGFL) favourite disciplines from the very beginning. For this reason, we also put a lot of effort into maintaining our own database and have developed numerous analysis tools and key figure tables on this basis.

Corporate Name Change

Financial Calendar

Interviews, Quotes, Analyses

IR-Quick Check

Annual Reports

Does news drive share prices or does the chain of effects run the other way round - as is often assumed? Well, at boersengefluester.de we offer you all kinds of ways to follow daily stock market events. Take a look at our apps on the subject of news.

Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.

Pentixapharm Holding

Quick Links

Network

Partner

Contact

Pentixapharm Holding

Would you like to see fewer adverts? Simply register for a user account. Registration is free and significantly reduces the number of adverts.

Quick Links

Network

Partner

Contact